Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

348
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
348
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

5.5K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
5.5K
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

131
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
131
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

3.7K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
3.7K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

5.5K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maintaining qualification for 340B.

Healthcare financial management : journal of the Healthcare Financial Management Association·2016
Same author

PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.

European journal of nuclear medicine and molecular imaging·2015
Same author

Mechanical temporal fluctuation induced distance and force systematic errors in Casimir force experiments.

Journal of physics. Condensed matter : an Institute of Physics journal·2015
Same author

DSH payment under the ACA. Steps to receiving your fair share.

Healthcare financial management : journal of the Healthcare Financial Management Association·2015
Same author

Synergistic enhancement in the co-gelation of salt-soluble pea proteins and whey proteins.

Food chemistry·2013
Same author

(124)I-huA33 antibody PET of colorectal cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2011

Related Experiment Video

Updated: Mar 26, 2026

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.7K

Fast track to 340B.

Robert F Gricius, Douglas Wong

    Healthcare Financial Management : Journal of the Healthcare Financial Management Association
    |February 12, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Newly qualified hospitals can expedite participation in the 340B Drug Pricing Program. Key steps include analyzing Medicaid and SSI utilization data, assessing early cost report filing, and preparing enrollment documents.

    More Related Videos

    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
    16:19

    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

    Published on: September 13, 2014

    13.3K
    Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
    12:49

    Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

    Published on: August 17, 2022

    3.3K

    Related Experiment Videos

    Last Updated: Mar 26, 2026

    Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
    07:10

    Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

    Published on: May 20, 2019

    14.7K
    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
    16:19

    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

    Published on: September 13, 2014

    13.3K
    Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
    12:49

    Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

    Published on: August 17, 2022

    3.3K

    Area of Science:

    • Health Economics
    • Healthcare Administration

    Background:

    • The 340B Drug Pricing Program significantly impacts hospital finances.
    • Newly eligible hospitals face enrollment complexities and delays.

    Purpose of the Study:

    • To outline a strategy for newly qualified hospitals to achieve fast-track approval into the 340B program.
    • To identify critical steps for efficient program participation.

    Main Methods:

    • Utilize data analytics to evaluate Medicaid utilization and Supplemental Security Income (SSI) eligibility.
    • Assess the feasibility of early submission for cost reports.
    • Prepare comprehensive documentation for the initial enrollment process.

    Main Results:

    • A structured approach can accelerate the 340B enrollment timeline.
    • Data-driven assessment and proactive documentation are crucial for fast-track approval.

    Conclusions:

    • Newly eligible hospitals can leverage specific strategies for expedited 340B program entry.
    • Efficient data analysis and preparation streamline the enrollment pathway.